What type of study is this?

This is a Pre-Registered Trial study.

What question did this study set out to answer?

The study aims to assess the effectiveness of dexamethasone in enhancing rituximab responses in ITP patients.

December 8, 2025Blood

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial shows improved responses with dexamethasone added to rituximab in ITP patients, suggesting better outcomes.

The study aims to assess the effectiveness of dexamethasone in enhancing rituximab responses in ITP patients.
Prospective multi-center, international, two-phase, double-randomized trial
Patients randomly assigned to rituximab with or without dexamethasone during induction phase
Secondary phase evaluated maintenance therapy with rituximab or placebo after initial response.
37.5% of patients responded to rituximab alone versus 60.3% with dexamethasone addition
Time to first bleeding episode was longer in the dexamethasone group
33 serious adverse events reported during the induction phase.

Tsykunova et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark